Company Quick10K Filing
Global Arena Holding
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-10-01
10-Q 2020-03-31 Filed 2020-09-25
10-K 2019-12-31 Filed 2020-09-11
10-Q 2019-09-30 Filed 2020-01-14
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-06-20
10-K 2018-12-31 Filed 2019-05-20
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-05-04
10-Q 2017-09-30 Filed 2017-11-30
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-06-12
10-K 2016-12-31 Filed 2017-05-30
10-Q 2016-09-30 Filed 2017-02-23
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-08-18
10-K 2015-12-31 Filed 2016-05-09
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-06-02
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-18
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-09-06
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-15
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-30
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-22
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-28
10-Q 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-05-17 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-15
8-K 2020-03-31
8-K 2020-03-26
8-K 2019-03-13
8-K 2018-11-16
8-K 2018-06-28
8-K 2018-01-29

Global Arena Holding Financials

GAHC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash6961519937712774130464991242644871251420152302169335447
Accounts Receivable21
Inventory
PP&E100987643
Assets9781,0831,1131,0951,2829738698941,067329280419397346351344343359429869730823757789832796
Accounts Payable723721721721317331
Long-Term Debt8221,4432,4632,1791,8462,5203,0703,6393,874
Liabilities8541,2971,2972,3573,1483,3363,2054,3754,2562,1533,8074,3624,5264,8737,4275,0155,9077,85913,15011,14816,4739,0977,6848,2356,8917,256
Stockholders' Equity293-1514-1,106-1,707-2,151-2,108-3,236-2,703-1,330-3,527-7,635-4,129-5,564-7,501-12,720-10,278-15,743-8,274-6,927-7,446-6,059-6,460
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue2191772032,7592,3872,1172,5162,8943,597382343756673231825378275671132820218957
Cost of Revenue
Gross Profit
R&D
SG&A75
Tax0148900000000000000000
Net Income-620-1,134-224-368-1,339-942-1,015-1,520-4391,248-1,321-773-1,172-496-2,7052,234-1,061-2,187-5,4861,141-7,1566,7191,030-972-451
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-09-302015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-420-286-313-447-263-110-191-451-237-138-214-100-186-160-207-467-491-316-126-357-137
Cash Investing-18636000-108-110-11-10-75-225-70-44000
Cash Financing4122765051612101655255911291082199220617527890735240960390100